The Daily Experience of Somatic Anxiety and Worry in Lung Cancer Survivors
The Daily Experience of Somatic Anxiety and Worry in Lung Cancer Survivors
批准号:
7737719
负责人:
Keith Robert Aronson
金额:
$7.6万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-01 至 2011-06-30
关键词:
AccountingAcheAdultAnxietyApplied ResearchAttentionBasic ScienceBenignCancer PatientCancer SurvivorCancer SurvivorshipCatchment AreaCognitiveCountyDataDiagnosisDistressEmotionalEquationEvaluationFaceFrightGoalsHealthHealth ProfessionalHealth StatusIndividualInstitutesInterventionInterviewInvestigationLightLinear ModelsLiteratureLiverLongevityMalignant NeoplasmsMalignant neoplasm of lungMalignant neoplasm of prostateMeasuresMinorModelingNeoplasm MetastasisNeurotic DisordersNon-Small-Cell Lung CarcinomaNoseOvarianPainPancreasParticipantPennsylvaniaPerceptionPersonalityPersonsPrevalencePreventionPreventive InterventionProcessPsychological ModelsPsychosocial Assessment and CareQuality of lifeRecurrenceRegulationRelative (related person)ReportingResearchResearch PersonnelRiskRuralSamplingSick RoleSocial supportStagingStressSurvivorsSymptomsTelephone InterviewsTestingTheoretical modelTimeVariantWomanWorkbasedesignemotional reactionexperienceimprovedinnovationmalignant breast neoplasmmedically underservedmeetingsmenpatient populationprospectivepsychologicpsychosocialpublic health relevancesocialstressorsurvivorshiptheories
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
The Daily Experience of Somatic Anxiety and Worry in Lung Cancer Survivors Virtually all cancer survivors report experiencing distressing cognitive and emotional reactions (e.g., anxiety, worry, fear) to the status of their health, particularly after discharge from treatment. Somatic anxiety and worry (SAW) has a detrimental impact on quality of life. While SAW is ubiquitous in cancer survivors, virtually nothing is known about the factors that exacerbate or diminish the degree to which the phenomenon is experienced. The research undertaken in this study frames the experience of SAW within a cognitive psychological model of symptom perception. Specifically, the model predicts that the daily experience of SAW is related to (a) internally focused attention regulation, (b) a somatic attributional style, (c) somatic symptoms, (d) neuroticism, and (e) daily stress. Participants will be adult (18 years+), non-small cell, lung cancer survivors seen at the Penn State Cancer Institute, at either Stage 1 or 2, and are a minimum of 60- days, and a maximum of 24-months, post-discharge from treatment. Participants will complete a brief battery of measures and will then be called over eight consecutive evenings to complete a brief telephone interview. During the interview, participants will be asked about the day's stressful experiences, somatic symptoms experienced, and any concomitant SAW. The goodness of fit of the model explaining SAW will be assessed using structural equation modeling. The study will also examine the kinds of stress experiences that are most and least predictive of SAW, and determine the degree to which one day's experiences influence the degree to which SAW is experienced on subsequent days. Finally, we will determine the degree to which the level of SAW on one day influences the number of somatic symptoms, stress, and SAW experienced on subsequent days. Ultimately, the goal of this research is to develop an empirically supported psychosocial prevention/intervention approach to SAW with cancer survivors. The basic research findings should be directly translatable to psychosocial prevention/intervention strategies with cancer survivors experiencing SAW, as well as provide an impetus for additional basic and applied research on SAW.
PUBLIC HEALTH RELEVANCE: This study will be the first to shed light on the day-to-day manifestation of somatic anxiety and worry (SAW) in lung cancer survivors. By investigating the predictors of SAW in lung cancer survivors, our results will inform prevention and intervention efforts to improve the quality of life of lung cancer survivors, as well as other survivors with relatively short projected life spans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SOMATIC ANXIETY & DISTRESS: A STRESS-DIATHESIS MODEL IN CANCER SURVIVORS
-
批准号:7951278
-
项目类别:
-
资助金额:$0.32万
-
财政年份:2009
-
负责人:Keith Robert Aronson
-
依托单位:
The Daily Experience of Somatic Anxiety and Worry in Lung Cancer Survivors
-
批准号:7879456
-
项目类别:
-
资助金额:$7.58万
-
财政年份:2009
-
负责人:Keith Robert Aronson
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于无机基质固定碳点光学探针研究有机磷农药暴露AChE响应的活体测量
-
批准号:
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2024
-
负责人:冯锋
-
依托单位:
转录因子BMAL1调控AChE在昼夜节律紊乱致认知损害中的作用及分子机制
-
批准号:2024Y9230
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:姜雨
-
依托单位:
基于AChE/NLRP3 靶点研究垂穗石松中抗AD新型黄酮苷
吐星酸酯类成分的发现及作用机制研究
-
批准号:2024JJ8138
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:谭蕾红
-
依托单位:
基于GSK-3β/AChE双重抑制的抗AD杂交分子的设计、合成及作用机制研究
-
批准号:22367005
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:董永喜
-
依托单位:
基于可逆界面传质调控机制的AChE固定化荧光传感器及有机磷农药高灵敏抗干扰速测
-
批准号:32372427
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:冷远逵
-
依托单位:
利用微流体技术合成富缺陷MOFs材料定向捕获AChE酶构筑高性能传感界面
-
批准号:32302225
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:宋丹丹
-
依托单位:
抗基质干扰导向的AChE仿生荧光探针的设计合成及农药残留速测应用
-
批准号:--
-
项目类别:面上项目
-
资助金额:53万元
-
批准年份:2022
-
负责人:郝振霞
-
依托单位:
基于高分辨活性轮廓分析的中药AChE/GSK3β双靶点抑制剂高内涵筛选研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:翟蔓华芸
-
依托单位:
新型AChE/NLRP3双靶点抑制剂—藤石松中抗AD新颖黄酮苷吐星酸酯类成分的发现及作用机制研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:刘阳
-
依托单位:
基于AchE靶点的苗药三两银抗阿尔兹海默症甾体生物碱类化合物发现与作用机制研究
-
批准号:82260833
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:於祥
-
依托单位: